Aveanna Healthcare (NASDAQ:AVAH) Releases FY 2021 Earnings Guidance

Aveanna Healthcare (NASDAQ:AVAH) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $- for the period. The company issued revenue guidance of $1.75 B-.

AVAH stock traded up $0.08 during mid-day trading on Thursday, reaching $12.68. The company’s stock had a trading volume of 19,048 shares, compared to its average volume of 1,101,061. Aveanna Healthcare has a fifty-two week low of $9.80 and a fifty-two week high of $13.00.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Monday, May 24th. The company reported $0.08 EPS for the quarter, beating the Zacks’ consensus estimate of $0.07 by $0.01. On average, sell-side analysts expect that Aveanna Healthcare will post 0.43 earnings per share for the current year.

AVAH has been the subject of several recent research reports. Raymond James initiated coverage on shares of Aveanna Healthcare in a research report on Monday, May 24th. They issued a strong-buy rating and a $15.00 price target for the company. Deutsche Bank Aktiengesellschaft began coverage on shares of Aveanna Healthcare in a research note on Monday, May 24th. They set a buy rating and a $13.50 price target on the stock. Royal Bank of Canada began coverage on shares of Aveanna Healthcare in a research note on Monday, May 24th. They issued an outperform rating and a $16.00 price objective on the stock. JPMorgan Chase & Co. assumed coverage on shares of Aveanna Healthcare in a research note on Monday, May 24th. They issued a neutral rating and a $14.00 price objective on the stock. Finally, Barclays initiated coverage on shares of Aveanna Healthcare in a report on Monday, May 24th. They issued an overweight rating and a $20.00 target price on the stock. One analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $15.65.

In related news, CFO David Afshar bought 4,284 shares of the stock in a transaction on Friday, April 30th. The shares were purchased at an average price of $11.67 per share, with a total value of $49,994.28. Following the purchase, the chief financial officer now owns 14,534 shares in the company, valued at $169,611.78. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.

Featured Article: Are we seeing the beginning of a new bubble?

Earnings History and Estimates for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.